Welcome to LookChem.com Sign In|Join Free

CAS

  • or

629-80-1

Post Buying Request

629-80-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

629-80-1 Usage

Description

Hexadecanal, also known as palmitaldehyde, is a fatty aldehyde with the chemical formula C16H32O. It is a white solid with a characteristic fatty odor. Hexadecanal is commonly used in the production of various lipids and fatty acids, which are essential components in the chemical, pharmaceutical, and cosmetic industries.

Uses

Used in Chemical Industry:
Hexadecanal is used as a raw material for the production of lipids and fatty acids, which are essential components in the synthesis of various chemicals, including surfactants, lubricants, and plasticizers. These lipids and fatty acids are also used as additives in the manufacturing of cosmetics, pharmaceuticals, and other consumer products.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, hexadecanal is used as a starting material for the synthesis of various drugs and drug intermediates. The production of lipids and fatty acids derived from hexadecanal can be utilized in the formulation of medications, particularly those targeting skin and hair care.
Used in Cosmetic Industry:
Hexadecanal is used as an ingredient in the cosmetic industry, where it serves as a component in the formulation of various personal care products such as creams, lotions, and shampoos. The lipids and fatty acids derived from hexadecanal provide moisturizing and emollient properties, enhancing the texture and feel of these products.
Used in Flavor and Fragrance Industry:
Hexadecanal is also used in the flavor and fragrance industry due to its characteristic fatty odor. It is used as a component in the creation of various artificial flavors and fragrances, particularly those mimicking natural fatty or waxy scents.

Check Digit Verification of cas no

The CAS Registry Mumber 629-80-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,2 and 9 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 629-80:
(5*6)+(4*2)+(3*9)+(2*8)+(1*0)=81
81 % 10 = 1
So 629-80-1 is a valid CAS Registry Number.
InChI:InChI=1/C16H32O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h16H,2-15H2,1H3

629-80-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H1296)  Hexadecanal  >97.0%(GC)

  • 629-80-1

  • 1g

  • 1,690.00CNY

  • Detail

629-80-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name hexadecanal

1.2 Other means of identification

Product number -
Other names EINECS 211-111-0

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Food additives -> Flavoring Agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:629-80-1 SDS

629-80-1Synthetic route

1-Hexadecanol
36653-82-4

1-Hexadecanol

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With 4-acetylamino-2,2,6,6-tetramethylpiperidine-N-oxyl; toluene-4-sulfonic acid In dichloromethane 1) 0 deg C, 1 h, 2) r.t., 2.5 h;100%
With 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione In ethyl acetate at 60℃;99%
With pyridine; 1-chloro-1λ3-benzo[d][1,2]iodaoxol-3(1H)-one; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical In ethyl acetate at 20℃; for 1.5h;98%
n-hexadecanoyl chloride
112-67-4

n-hexadecanoyl chloride

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With tri-n-butyl-tin hydride; tetrakis(triphenylphosphine) palladium(0) In benzene for 0.166667h; Ambient temperature;97%
With ammonium hydroxide; formic acid In diethyl ether; chloroform for 0.333333h; Ambient temperature;95%
With Amberlyst A-26 in the BH4(1-) form in column at 4-5 ml In hexane91.04%
hexadecanyl bromide
112-82-3

hexadecanyl bromide

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With sodium hydrogencarbonate; dimethyl sulfoxide; sodium iodide at 115℃; for 2.25h;96%
Multi-step reaction with 3 steps
1: 1.) NaH / 1.) 1,2-dimethoxyethane, 15 min; 2.) dimethoxyethane, 5 h, reflux
2: 74 percent / permaleic acid
3: 1.) trifluoroacetic anhydride; 2.) K2CO3 / 1.) 10 min, r.t.; 2.) 40percent CH3CN/H2O, 10 min,
View Scheme
1-hexadecanol, trimethylsilyl ether
6221-90-5

1-hexadecanol, trimethylsilyl ether

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate; HZSM-5 zeolite In water for 0.166667h; microwave irradiation;93%
With chromium(VI) oxide; HZSM-5 zeolite for 0.03h; microwave irradiation;83%
1-hexadecylcarboxylic acid
57-10-3

1-hexadecylcarboxylic acid

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With ThxBHO-s-Bu In tetrahydrofuran at 25℃; for 96h;87%
Stage #1: 1-hexadecylcarboxylic acid With N,O-dimethylhydroxylamine*hydrochloride; N-ethyl-N,N-diisopropylamine; (bis-(2-methoxyethyl)amino)sulfur trufluoride In tetrahydrofuran; dichloromethane at 20℃; for 0.25h;
Stage #2: With diisobutylaluminium hydride In tetrahydrofuran; hexane; dichloromethane at -78℃; for 1h;
83%
With Bis(N-methylpiperazinyl) aluminum hydride In tetrahydrofuran for 8h; Heating;79%
1-octadecanol
112-92-5

1-octadecanol

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
Stage #1: 1-octadecanol With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -10℃; for 0.0833333h; Swern Oxidation; Inert atmosphere;
Stage #2: In dichloromethane at -10℃; for 0.25h; Swern Oxidation; Inert atmosphere;
87%
palmitonitrile
629-79-8

palmitonitrile

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With hydrogenchloride; diethyl ether; tin(ll) chloride und beim Verseifen des Reaktionsprodukts mit warmem Wasser;
2-hydroxyheptadecanoic acid
25022-78-0

2-hydroxyheptadecanoic acid

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
at 275 - 280℃;
17-oxatritriacontane
4113-12-6

17-oxatritriacontane

A

Hexadecane
544-76-3

Hexadecane

B

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
at 270℃;
at 270℃; Erhitzung;
N-methyl-palmitanilide
2157-84-8

N-methyl-palmitanilide

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With tetrahydrofuran; lithium aluminium tetrahydride
(E)-3-Ureido-but-2-enoic acid ethyl ester
5435-44-9, 22243-66-9

(E)-3-Ureido-but-2-enoic acid ethyl ester

2,4,6-tripentadecyl-[1,3,5]trioxane

2,4,6-tripentadecyl-[1,3,5]trioxane

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
bei der Destillation;
1-iodohexadecane
544-77-4

1-iodohexadecane

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With trimethylamine-N-oxide In chloroform
Multi-step reaction with 2 steps
1: 71 percent / AgNO2 / diethyl ether / 0 deg C, 15 h, next room temperature, 8 h
2: 1.) NaH, tert-butyl alcohol, 2.) KMnO4, H3BO3 / 1.) pentane, 20 min, 2.) ethyl acetate, water, 10 min
View Scheme
N,N-dimethylpalmitamide
3886-91-7

N,N-dimethylpalmitamide

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With lithium dihydrido-bis(2-methoxyethoxo)aluminate In diethyl ether; toluene
1-hexadecanoyl-3,5-dimethyl-1H-pyrazole
70583-60-7

1-hexadecanoyl-3,5-dimethyl-1H-pyrazole

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With lithium aluminium tetrahydride In diethyl ether Ambient temperature;
hexadec-1-yne
629-74-3

hexadec-1-yne

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With borane N,N-diethylaniline complex; dihydrogen peroxide; sodium acetate; benzo[1,3,2]dioxaborole 1.) benzene, 25 deg C, 24 h; Yield given. Multistep reaction;
With borane N,N-diethylaniline complex; dihydrogen peroxide; sodium acetate; benzo[1,3,2]dioxaborole Yield given. Multistep reaction;
1-Hexadecanol
36653-82-4

1-Hexadecanol

A

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

B

2-n-dodecyltetrahydrofuran
92957-63-6

2-n-dodecyltetrahydrofuran

Conditions
ConditionsYield
With lead(IV) acetate; manganese(II) acetate In benzene Heating;A 86 % Chromat.
B 7 % Chromat.
hexadecanoic acid methyl ester
112-39-0

hexadecanoic acid methyl ester

A

formaldehyd
50-00-0

formaldehyd

B

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With dimethylsulfide borane complex; pyridinium chlorochromate 1) THF, reflux, 1 h, 2.) CH2Cl2, reflux, 1 h; Yield given. Multistep reaction;
1-nitro-hexadecane
66271-50-9

1-nitro-hexadecane

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With potassium permanganate; boric acid; sodium hydride; tert-butyl alcohol 1.) pentane, 20 min, 2.) ethyl acetate, water, 10 min; Yield given. Multistep reaction;
cetyl palmitate
540-10-3

cetyl palmitate

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With dimethylsulfide borane complex; pyridinium chlorochromate 1) THF, reflux, 1 h, 2.) CH2Cl2, reflux, 1 h; Yield given. Multistep reaction;
1-Phenyl-heptadecan-2-ol
19366-26-8

1-Phenyl-heptadecan-2-ol

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With lead(IV) acetate; iodine In benzene Heating; Yield given;
With lead(IV) acetate; iodine In benzene for 6h; Heating; Yield given;
2-hexadecylsulfinyl-3,6-diisopropylpyrazine
120061-38-3

2-hexadecylsulfinyl-3,6-diisopropylpyrazine

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

Conditions
ConditionsYield
With potassium carbonate; trifluoroacetic anhydride 1.) 10 min, r.t.; 2.) 40percent CH3CN/H2O, 10 min,; Yield given. Multistep reaction;
n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

methyl (triphenylphosphoranylidene)acetate
21204-67-1

methyl (triphenylphosphoranylidene)acetate

methyl trans-2-octadecenoate
14663-11-7

methyl trans-2-octadecenoate

Conditions
ConditionsYield
In dichloromethane at 20℃; for 17h; Inert atmosphere;100%
Wittig reaction;
n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

(tert-Butoxycarbonylmethylene)triphenylphosphorane
86302-43-4

(tert-Butoxycarbonylmethylene)triphenylphosphorane

tert-butyl (E)-2-octadecenoate

tert-butyl (E)-2-octadecenoate

Conditions
ConditionsYield
In dichloromethane at 25℃; for 12h; Wittig Rearrangement;99%
In dichloromethane at 20℃; for 12h; Wittig Olefination;98.8%
n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

1-Hexadecanol
36653-82-4

1-Hexadecanol

Conditions
ConditionsYield
With chloro-trimethyl-silane; nickel boride In diethylene glycol dimethyl ether; N,N-dimethyl-formamide for 1h; Ambient temperature;98%
With magnesium; tin(ll) chloride In tetrahydrofuran for 0.25h;98%
With sodium tetrahydroborate; nickel dichloride In tetrahydrofuran at 20℃; for 0.166667h;92%
With water; nickel dichloride; zinc In N,N-dimethyl-formamide for 5h; Ambient temperature;65%
With acetic acid; zinc und nachfolgender Verseifung des erhaltenen Cetylacetats mittels alkoholischer Kalilauge;
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

3,3',5,5'-tetramethyl-4,4'-dimethoxy benzhydrylamine
1072879-54-9

3,3',5,5'-tetramethyl-4,4'-dimethoxy benzhydrylamine

ethyl (2S,3S)-1-(bis(4-methoxy-3,5-dimethylphenyl)methyl)-3-pentadecylaziridine-2-carboxylate
1606993-91-2

ethyl (2S,3S)-1-(bis(4-methoxy-3,5-dimethylphenyl)methyl)-3-pentadecylaziridine-2-carboxylate

Conditions
ConditionsYield
Stage #1: 3,3',5,5'-tetramethyl-4,4'-dimethoxy benzhydrylamine With triphenylborane In toluene at 80℃; for 0.5h; Inert atmosphere; Sealed tube; Schlenk technique;
Stage #2: diazoacetic acid ethyl ester; n-hexadecylaldehyde In toluene Inert atmosphere; Sealed tube; Schlenk technique; Molecular sieve; stereoselective reaction;
97%
Stage #1: 3,3',5,5'-tetramethyl-4,4'-dimethoxy benzhydrylamine With triphenylborane; (R)-t-Bu2VANOL In toluene at 80℃; for 0.5h; Inert atmosphere; Schlenk technique;
Stage #2: diazoacetic acid ethyl ester; n-hexadecylaldehyde In toluene at -10℃; for 24h; Molecular sieve; Inert atmosphere; Schlenk technique; enantioselective reaction;
96.7%
Stage #1: 3,3',5,5'-tetramethyl-4,4'-dimethoxy benzhydrylamine With triphenylborane; (2S)-(-)-3,3'-diphenyl-(2,2'-binaphthalene)-1,1'-diol In toluene at 80℃; for 0.5h; Inert atmosphere;
Stage #2: diazoacetic acid ethyl ester; n-hexadecylaldehyde In toluene at -10℃; for 24h; Reagent/catalyst; Temperature; Inert atmosphere; Molecular sieve; stereoselective reaction;
60%
3-bromo-3,3-difluropropene
420-90-6

3-bromo-3,3-difluropropene

n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

3,3-difluorononadec-1-en-4-ol
1310740-06-7

3,3-difluorononadec-1-en-4-ol

Conditions
ConditionsYield
With indium In tetrahydrofuran; water at 20 - 60℃; Inert atmosphere;93%
n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

1,2-diamino-9,10-anthraquinone
1758-68-5

1,2-diamino-9,10-anthraquinone

C30H38N2O2

C30H38N2O2

Conditions
ConditionsYield
With phosphotungstic acid; oxygen at 80℃; for 2h; Green chemistry; chemoselective reaction;93%
n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

triphenylarsonium salt of bromoacetaldehyde
103698-50-6

triphenylarsonium salt of bromoacetaldehyde

(E)-octadec-2-enal
51534-37-3

(E)-octadec-2-enal

Conditions
ConditionsYield
With potassium carbonate In tetrahydrofuran; diethyl ether; water at 25℃; for 17.5h;90%
n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

(3R,5R)-(+)-2,6-dimethyl-3,5-heptanediol
128899-83-2

(3R,5R)-(+)-2,6-dimethyl-3,5-heptanediol

(4R,6R)-2-n-pentadecyl-4,6-diisopropyl-1,3-dioxane

(4R,6R)-2-n-pentadecyl-4,6-diisopropyl-1,3-dioxane

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene for 3h; Heating;90%
n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

17-hydroxydotriacontan-16-one
6790-29-0

17-hydroxydotriacontan-16-one

Conditions
ConditionsYield
With 3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; triethylamine In ethanol at 80℃; for 3h; Inert atmosphere;89%
With triethylamine; 4,5-dimethylthiazole bound on chloromethylated polystyrene copolymer In ethanol; chloroform for 96h; Ambient temperature;53%
With triethylamine In ethanol at 80℃; for 96h;51%
With 3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride In ethanol for 3h; Inert atmosphere; Reflux;
n-hexadecylaldehyde
629-80-1

n-hexadecylaldehyde

allyltitanium complex

allyltitanium complex

(S)-nonadec-1-en-4-ol
528867-18-7

(S)-nonadec-1-en-4-ol

Conditions
ConditionsYield
In diethyl ether at -78℃; for 4h;89%

629-80-1Relevant articles and documents

From T-antigen to plasmalogen-derived aldehydes: The identification of a marker of colorectal cancer in human rectal mucous

Krepinsky, Jiri J.,Kandel, Gabor P.,Yeung, Ka Sing,Chociej, Jacek,Chen, Min,Cohen, Gideon,Douglas, Stephen P.,Furrer, Rudolf,Kukreti, Vishal,Lupescu, Niculina,Richens, Enoka,Tanner, Keith L.

, p. 109 - 117 (2003)

Recently, a simple noninvasive screening test for colorectal cancer was proposed, based on a hypothesis involving galactose-containing carbohydrate moieties such as the Thomsen-Friedenreich antigen. According to the hypothesis, such carbohydrate moieties, present in the human rectal mucous of patients with colorectal cancer, can be specifically oxidized with galactose oxidase to form substances that, upon reaction with Schiff reagent, yield purple (magenta) coloured compounds. While evaluating this proposed test, we discovered that the colour formation is not due to the proposed reaction between oxidized galactose moieties present in rectal mucous and Schiff reagent. We found instead that the mucous from colorectal cancer patients contains compounds that form purple (magenta) adducts with the Schiff reagent directly, i.e., they do not require oxidation by galactose oxidase. We have identified these compounds as long-chain aliphatic aldehydes, mainly palmitic aldehyde C15H31CH=O and stearic aldehyde C17H35CH=O. We have further found that the aldehydes originate from plasmalogens present in the phospholipid fraction of the mucous obtained from colorectal cancer patients. The aldehydes, present in plasmalogens as enol ethers, are released by the acidity of the Schiff reagent and in turn react with the Schiff reagent to form the coloured adducts. Correct identification of these markers could lead to the development of a more accurate colorectal cancer screening tool and to a deeper understanding of colorectal carcinogenesis.

Muraki,Mukaiyama

, p. 875 (1975)

A dicarboxylic fatty acid derivative of paclitaxel for albumin-assisted drug delivery

Hackett, Michael J.,Joolakanti, Shyamsunder,Hartranft, Megan E.,Guley, Patrick C.,Cho, Moo J.

, p. 3292 - 3304 (2012)

Paclitaxel (PTX) is a potent chemotherapy for many cancers but it suffers from very poor solubility. Consequently, the TAXOL formulation uses copious amounts of the surfactant Cremophor EL to solubilize the drug for injection, resulting in severe hypersensitivity and neutropenia. In contrast to Cremophor EL, presented is a way to solubilize PTX by conjugation of a dicarboxylic fatty acid for specific binding to the ubiquitous protein, serum albumin. The conjugation chemistry was simplified to a single step using the activated anhydride form of 3-pentadecylglutaric (PDG) acid, which is reactive to a variety of nucleophiles. The PDG derivative is less cytotoxic than the parent compound and was found to slowly hydrolyze to PTX (~5% over 72h) in serum, tumor cytosol, and tumor tissue homogenate. When injected intravenously to tumor-bearing mice, [3H]-PTX in the TAXOL formulation was cleared rapidly with a half-life of 7 h. In the case of the PDG derivative of PTX, the drug is quickly distributed and approximately 20% of the injected dose remained in the vasculature experiencing a 23h half-life. These improvements from modifying PTX with the PDG fatty acid present the opportunity for PDG to become a generic modification for the improvement of many therapeutics.

Discovery of Anti-TNBC Agents Targeting PTP1B: Total Synthesis, Structure-Activity Relationship, in Vitro and in Vivo Investigations of Jamunones

Hu, Caijuan,Li, Guoxun,Mu, Yu,Wu, Wenxi,Cao, Bixuan,Wang, Zixuan,Yu, Hainan,Guan, Peipei,Han, Li,Li, Liya,Huang, Xueshi

supporting information, p. 6008 - 6020 (2021/05/06)

Twenty-three natural jamunone analogues along with a series of jamunone-based derivatives were synthesized and evaluated for their inhibitory effects against breast cancer (BC) MDA-MB-231 and MCF-7 cells. The preliminary structure-activity relationship revealed that the length of aliphatic side chain and free phenolic hydroxyl group at the scaffold played a vital role in anti-BC activities and the methyl group on chromanone affected the selectivity of molecules against MDA-MB-231 and MCF-7 cells. Among them, jamunone M (JM) was screened as the most effective anti-triple-negative breast cancer (anti-TNBC) candidate with a high selectivity against BC cells over normal human cells. Mechanistic investigations indicated that JM could induce mitochondria-mediated apoptosis and cause G0/G1 phase arrest in BC cells. Furthermore, JM significantly restrained tumor growth in MDA-MB-231 xenograft mice without apparent toxicity. Interestingly, JM could downregulate phosphatidylinositide 3-kinase (PI3K)/Akt pathway by suppressing protein-tyrosine phosphatase 1B (PTP1B) expression. These findings revealed the potential of JM as an appealing therapeutic drug candidate for TNBC.

Synthesis of (+/-)-Pregabalin and its novel lipophilic β-alkyl-substituted analogues from fatty chains

D'Oca, Caroline Da Ros Montes,Mass, Eduardo Bustos,Ongaratto, Renata Fontes,De Andrade, Arthur Motta,D'Oca, Marcelo G. Montes,Russowsky, Dennis

, p. 13230 - 13239 (2020/08/28)

In this work, were synthesized for the first time a series of new lipophilic β-alkyl substituted GABA derivatives from fatty alkyl chains. The synthesis of these GABA analogues was investigated by two different bicomponent approaches as a key step. The results showed low yields in the path from aliphatic nitroolefins and Meldrum's acid, whereas the Knoevenagel condensation between aliphatic aldehydes and Meldrum's acid afforded fatty alkylidenes in good yields (75-97%). These compounds were subsequently subjected to a conjugate addition reaction with nitromethane, resulting in the fatty Michael adducts (in 87-97% yields) which were in turn submitted to a one pot domino hydrolysis-decarboxylation, leading to the isolation of β-alkyl-substituted γ-nitro acids in good yields (78-92%). Finally, the reduction of the fatty γ-nitro acids allowed for the access to new lipophilic β-alkyl substituted GABA analogues, which were isolated in high yields (90-98%). The new methodology was also applied to the synthesis of antiepileptic drug (+/-)-Pregabalin, which was obtained after four steps in high overall yield. This journal is

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 629-80-1